{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:31:13Z","timestamp":1772767873258,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson&apos;s Research","doi-asserted-by":"publisher","award":["MJFF-000939"],"award-info":[{"award-number":["MJFF-000939"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson&apos;s Research","doi-asserted-by":"publisher","award":["MJFF-020718"],"award-info":[{"award-number":["MJFF-020718"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017770","name":"Kemper and Ethel Marley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002367"],"award-info":[{"award-number":["KL2TR002367"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["PD190057"],"award-info":[{"award-number":["PD190057"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.parkreldis.2025.107965","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:55:23Z","timestamp":1753142123000},"page":"107965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Frailty in prodromal Parkinson's disease in Medicare beneficiaries"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4375-6126","authenticated-orcid":false,"given":"George K.","family":"Karway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-1107","authenticated-orcid":false,"given":"Jordan A.","family":"Killion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2653-672X","authenticated-orcid":false,"given":"Irene M.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassu M.","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-8235","authenticated-orcid":false,"given":"Brad A.","family":"Racette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Camacho-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2025.107965_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2025.107965_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000495197","article-title":"Global burden of neurological disorders: from global burden of disease estimates to actions","volume":"52","author":"Feigin","year":"2019","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.parkreldis.2025.107965_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2025.107965_bib4","series-title":"Parkinson's Disease: Pathogenesis and Clinical Aspects","article-title":"Parkinson's disease: Etiology, Neuropathology, and Pathogenesis","author":"Kouli","year":"2018"},{"key":"10.1016\/j.parkreldis.2025.107965_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3233\/JPD-213007","article-title":"Prevalence of prodromal symptoms of Parkinson's disease in the late middle-aged population","volume":"12","author":"Roos","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2025.107965_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ageing\/afaa112","article-title":"Frailty, a multisystem ageing syndrome","volume":"49","author":"Thillainadesan","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.parkreldis.2025.107965_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies","volume":"50","author":"O'Caoimh","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.parkreldis.2025.107965_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10522-017-9716-6","article-title":"Frailty phenotype and the role of levodopa challenge test in geriatric inpatients with mild parkinsonian signs","volume":"18","author":"Seiffert","year":"2017","journal-title":"Biogerontology"},{"key":"10.1016\/j.parkreldis.2025.107965_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.dld.2018.03.010","article-title":"Frailty and the gut","volume":"50","author":"Di Sabatino","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.parkreldis.2025.107965_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ggi.14362","article-title":"Differences and overlaps between frailty and Parkinson's disease","volume":"22","author":"Ebina","year":"2022","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.parkreldis.2025.107965_bib11","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Cardiovascular health study collaborative research G. Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000492572","article-title":"Prevalence and associated factors of sarcopenia and frailty in Parkinson's disease: a cross-sectional study","volume":"65","author":"Peball","year":"2019","journal-title":"Gerontology"},{"key":"10.1016\/j.parkreldis.2025.107965_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.parkreldis.2007.10.004","article-title":"Frailty in Parkinson's disease and its clinical implications","volume":"14","author":"Ahmed","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2025.107965_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2018.06.020","article-title":"Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease","volume":"56","author":"Tan","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2025.107965_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fnagi.2019.00283","article-title":"Associations between cognitive functions and physical frailty in patients with Parkinson's disease","volume":"11","author":"Lin","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib16","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/mds.28561","article-title":"Claims-based frailty and outcomes: applying an aging measure to older adults with Parkinson's disease","volume":"36","author":"Abraham","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2025.107965_bib17","first-page":"206","article-title":"Frailty in patients with Parkinson's disease: associations with disability and timed up and Go","volume":"58","author":"\u00d6zer","year":"2021","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.parkreldis.2025.107965_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/gerona\/glaa191","article-title":"Frailty and prodromal Parkinson's disease: results from the HELIAD study","volume":"76","author":"Ntanasi","year":"2021","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamaneurol.2023.0183","article-title":"Physical frailty, genetic predisposition, and incident Parkinson disease","volume":"80","author":"Zheng","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2025.107965_bib20","doi-asserted-by":"crossref","first-page":"E744","DOI":"10.9778\/cmajo.20200248","article-title":"Effectiveness of nutrition interventions and combined nutrition and physical activity interventions in older adults with frailty or prefrailty: a systematic review and meta-analysis","volume":"9","author":"Racey","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.parkreldis.2025.107965_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12877-019-1196-x","article-title":"What are the most effective interventions to improve physical performance in pre-frail and frail adults? A systematic review of randomised control trials","volume":"19","author":"Kidd","year":"2019","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.parkreldis.2025.107965_bib22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/gerona\/glx229","article-title":"Measuring frailty in Medicare data: development and validation of a claims-based frailty index","volume":"73","author":"Kim","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/gerona\/gly197","article-title":"Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study","volume":"74","author":"Kim","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.0000000000004536","article-title":"A predictive model to identify Parkinson disease from administrative claims data","volume":"89","author":"Searles","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2025.107965_bib25","doi-asserted-by":"crossref","first-page":"e2155","DOI":"10.1212\/WNL.0000000000005678","article-title":"Use of medical care biases associations between Parkinson disease and other medical conditions","volume":"90","author":"Gross","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2025.107965_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2025.107965_bib27","article-title":"Frailty in Parkinson's disease: a systematic review and meta-analysis","volume":"4","author":"McMillan","year":"2021","journal-title":"Clin. Park Relat. Disord."},{"key":"10.1016\/j.parkreldis.2025.107965_bib28","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1007\/s10072-022-06347-7","article-title":"Frailty and cognitive impairment in Parkinson's disease: a systematic review","volume":"43","author":"Sousa-Fraguas","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib29","doi-asserted-by":"crossref","DOI":"10.1590\/0034-7167-2022-0096","article-title":"Factors associated with frailty syndrome in elderly people with Parkinson's disease","volume":"75","author":"Couto","year":"2022","journal-title":"Rev. Bras. Enferm."},{"key":"10.1016\/j.parkreldis.2025.107965_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2022.05.004","article-title":"Frailty in Parkinson's disease and its association with early dementia: a longitudinal study","volume":"99","author":"Borda","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2025.107965_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40520-024-02922-4","article-title":"Associations between frailty and cognitive impairment in Parkinson's disease: a cross-sectional study","volume":"37","author":"Sousa-Fraguas","year":"2025","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.parkreldis.2025.107965_bib32","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1007\/s00415-021-10873-3","article-title":"The role of frailty in Parkinson's disease: a cross-sectional study","volume":"269","author":"Belvisi","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2025.107965_bib33","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/gerona\/glz224","article-title":"Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the U.S. Medicare data","volume":"75","author":"Kim","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib34","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1159\/000534131","article-title":"Is frailty different in younger adults compared to Old? Prevalence, characteristics, and risk factors of early-life and Late-life frailty in samples from Sweden and UK","volume":"69","author":"Bai","year":"2023","journal-title":"Gerontology"},{"key":"10.1016\/j.parkreldis.2025.107965_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrm.2017.68","article-title":"Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases","volume":"18","author":"Kubben","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.parkreldis.2025.107965_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson's disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2025.107965_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040475","article-title":"Inflammation and oxidative stress in frailty and metabolic syndromes-two sides of the same coin","volume":"13","author":"Dzi\u0119gielewska-G\u0119siak","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.parkreldis.2025.107965_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?","volume":"23","author":"Blesa","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2025.107965_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-2009-1099","article-title":"The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited","volume":"17","author":"Taylor","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.parkreldis.2025.107965_bib40","first-page":"697","article-title":"Parkinson's disease and cancer risk: a systematic review and meta-analysis","volume":"21","author":"Bajaj","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.parkreldis.2025.107965_bib41","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","article-title":"The prevalence and outcomes of frailty in older cancer patients: a systematic review","volume":"26","author":"Handforth","year":"2015","journal-title":"Ann. Oncol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025007060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025007060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:41:56Z","timestamp":1772764916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802025007060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"alternative-id":["S1353802025007060"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107965","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frailty in prodromal Parkinson's disease in Medicare beneficiaries","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107965"}}